Amendment #2 to Convertible Promissory Note Originally Dated November 14, 2012Convertible Promissory Note • April 18th, 2013 • Amarantus Bioscience Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 18th, 2013 Company Industry JurisdictionThis Amendment to the Convertible Promissory Note originally entered into between Amarantus Biosciences, Inc. ("Amarantus") and Dominion Capital, LLC ("Dominion") on November 14, 2012 (the "Original Agreement") is entered into on this 25th day of January, 2013.